Since the beginning of time, mankind has pondered the question of what it means to be alive. When, precisely, can one be considered a human being? With the advent of stem cell research, we are forced to confront this question head-on. Human embryonic stem cells have enormous medical potential; by harnessing the power of their undifferentiated state, we may be able to cure diseases and disabilities that have plagued mankind for millennia. Rather than simply treating the symptoms of debilitating conditions, we may be able to attack the diseases at their source, working from within the body itself. However, obtaining embryonic stem cells, despite the many benefits that may result, poses many new ethical questions. Embryonic stem cells are generated during the early stages of the formation of a human embryo. These cells adhere to the wall of the blastocyst and, in the process of obtaining them, the embryo is destroyed. The ethical dilemma is this; does this tiny but powerful group of cells constitute a human life, and, if so, it is justifiable to take it in order to save others?
What are Embryonic Stem Cells?
A fertilized embryo must undergo a series of divisions in order to grow. There are many different types of cells in an adult human, but, with the exception of red blood cells and lymph cells, every cell in the human body contains an identical genome. [5] If all cells contain an identical DNA sequence and originate from the same source, how does each cell know what to become? The answer lies in a population of cells known as stem cells. To be classified as a stem cell requires the possession of two key abilities
Unlike somatic cells, stem cells begin, not with a single fate, but in an undifferentiated state. This initial lack of specificity is crucial, for their division has the ability to field more unspecified cells or ones that will eventually become any cell in the organism. [3] The earliest stem cells are known as totipotent, meaning that they have the ability to differentiate into any cell in the embryo or the resulting adult. As the cells divide, they progressively lose their totipotent abilities, becoming more and more specified. The egg-sperm unit divides every 12-18 hours; first from two cells into four, then eight, then sixteen. [5] After this third cell division, totipotent cells give rise to pluripotent stem cells, which can become nearly any cell in the body. The unit is now a hollow ball known as a blastula, and with pluripotent cells adhered to the wall in a clump known as the Inner Cell Mass. The wall will become the supportive placenta as the embryo grows, with the ICM becoming the embryo itself. [7] As the pluripotent cells divide, they develop into cells called Lineage Restricted Stem Cells, then Progenitor Cells, and finally Differentiated Cells with pre-determined function. [See Figure 1] Each time the cell divides, it becomes more highly specified, and less plastic in terms of medical potential.
Why use Embryonic Stem Cells?
Because of their unique ability to generate so many different kinds of cells, and potential to reside in several areas of the human body, stem cells may eventually establish themselves as a cornerstone of 21st century medicine. Stem cell research has created an entirely new branch of medicine, called Regenerative Medicine. The specialty of this new discipline would be to repair organs or tissues affected or destroyed by age, disease or injury. [5] [6] [10] In at least one instance, experimental techniques have been highly successful. Scientists have developed large sheets of epidermal cells, which can be used to repair burns that have destroyed the full thickness of the skin. [10] Researchers are hoping to branch out and use the self-renewal and differentiating abilities of embryonic stem cells to treat diseases such as Parkinsons Disease or Type 1 Diabetes, or even paralysis resulting from damage to the spinal cord. [5] The hope is to learn to culture the cells and to manipulate their differentiation prior to inserting them into a patient. The cells would, in theory, be used to repair or re-grow the damaged tissues without being rejected by the patients immune system. In diabetic patients, the cells may be used to replace non-functioning pancreatic cells, while in paraplegic individuals the cells may replace the damaged components of the spine, allowing them to walk again.
An Ethical Mess: Are we taking a life in order to give life?
Obtaining embryonic stem cells for research purposes invariably results in the destruction of the embryo. Many individuals pose the question of whether this constitutes taking one human beings life in order to preserve the life of another. Currently, there are five major views concerning whether this ball of cells is in fact alive. Each viewpoint suggests that ones life begins at a different point in development.
Genetic View: Fertilization
Embryological View: Gastrulation A second position posits that one becomes human at gastrulation. [5] [12] Between 12 and 14 days after fertilization, the embryo begins to form germ layers, which will eventually develop into the three major tissue types found in adults. [17] Scientists view this as a turning point in development for, at the onset of gastrulation, the embryo can no longer divide to form twins. [12] If it survives, it is committed to forming a single individual. The blastula, now called a gastrula, develops three distinct layers of cells; the ectoderm, the mesoderm and the endoderm. The outermost layer, the ectoderm, will develop into the central nervous system, hair, fingernails and the epidermis of the skin. The endoderm, the innermost layer, gives rise to the lining of the digestive and respiratory tracts, and the glands such as the pancreas and liver. The mesoderm, the middle layer, is perhaps the most diverse, for it will eventually yield the muscles, the gonads, cartilage and the circulatory system, to name only a few. [17] Cells that are beginning to form the germ layers are too far along the differentiation pathway to be as useful as their predecessors. Considering the embryo to be alive only once gastrulation occurs is consistent with views in favor of Embryonic Stem Cell research. If one chooses this viewpoint, experimenting with embryos prior to this would not constitute taking a human life, for researchers would be obtaining the cells much earlier than the time of gastrulation.
Neurological View: EEG Activity The third major viewpoint is that human life begins with the acquisition of recognizable brain activity. At approximately, 24 weeks of age, there is a sufficient amount of coherence in the fetus developing brain that its activity can be seen via an electroencephalogram (EEG). [5] [18] In the United States, death is often determined by brain function. As stated in the Uniform Determination of Death Act, so-called brain death is defined as when the entire brain ceas[es] to function, irreversibly. The entire brain includes the brain stem, as well as the neocortex. The concept of entire brain distinguishes determination of death under this Act from neocortical death or persistent vegetative state. " [16] An individual whose cardiovascular and respiratory systems still function, but who produces no brain activity is considered to be dead. The fetal heart beat is present from approximately 7 weeks of gestational age, [4] but brain activity is not present until 24 weeks. This follows the logic present in US law; if we choose to define death in terms of the cessation of brain activity, we may choose to define life by its onset. This position also supports the use of stem-cell research, as the cells would be obtained months before the commencement of any recognizable brain activity.
Ecological View: Survival A fourth standpoint in terms of human life is viability. Some individuals choose to define human life as the point where the fetus is viable outside the mothers womb. [18] This has often been determined by lung function, as the respiratory system is both crucial for survival and one of the last systems to finish developing in the human fetus. Development of the lungs begins as early as week 4 of gestation, and continues until birth with the proliferation of the alveolar sacs. [8] [14] Surfactant, a compound produced in the alveoli beginning at about 34 weeks of age, reduces surface tension in the lungs and allows them to expand. Without this compound, infants have severely decreased lung function, which may prove fatal. Premature infants also have underdeveloped brain and immune function, which makes them highly susceptible to both apnea and infection as well as a host of other health problems. [14] Historically, many infants born before 28 weeks of age were unable to survive. [5] However, with the continued development of neonatal intensive care and cardio-pulmonary life support, the cutoff line for viability has become increasingly blurred. One is now forced to question whether a neonate born at 25 weeks of age with severely impaired brain and body function and kept alive only with assistance of machines is truly living.
The Birth View
Conclusion
Stem cells hold a power never before seen in medicine. If properly controlled, they may allow us to fight diseases that are now considered incurable. Their use, however, remains highly controversial, owing to the destruction of embryos in the process. Advocates against embryonic stem-cell research and use argue that the tiny ball of cells inside the blastula is alive. These individuals take the Fertilization viewpoint, maintaining that a human, no matter how small, is still a human. To them, the use of embryonic stem cells, even to save many others, can never justify the destruction of a human life. Supporters of embryonic stem cells maintain that zygotes are not truly human prior to gastrulation, brain function or even birth itself. Use of the inner cell mass in its earliest stages does not constitute ethical wrongdoing. The cells are obtained so early that the mass does not yet possess any human qualities, such as differentiated tissues or brain function. These individuals also point out that the majority of the blastocysts being used would not survive to begin with, and that anti-stem cell groups should see that the ends justify the means. Clearly stem cells have many potential benefits for mankind, but at the moment they are surrounded by a controversy that is unlikely to resolve itself any time soon. In the future, perhaps we will find a way to manipulate differentiated cells to have undifferentiated properties, thereby avoiding the ethics of embryonic stem cell use. However, until that day arrives, we must continue to ask ourselves the question of what it means to be human.
More:
Life and Death in Terms of Embryonic Stem Cells
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021